JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M306381200 on September 12, 2003

J. Biol. Chem., Vol. 278, Issue 47, 46541-46548, November 21, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/47/46541    most recent
M306381200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viatour, P.
Right arrow Articles by Chariot, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viatour, P.
Right arrow Articles by Chariot, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cytoplasmic I{kappa}B{alpha} Increases NF-{kappa}B-independent Transcription through Binding to Histone Deacetylase (HDAC) 1 and HDAC3*

Patrick Viatour{ddagger}, Sylvie Legrand-Poels§, Carine van Lint¶{ddagger}{ddagger}, Michael Warnier{ddagger}, Marie-Paule Merville{ddagger}||, Jacques Gielen{ddagger}, Jacques Piette§{ddagger}{ddagger}, Vincent Bours{ddagger}, and Alain Chariot{ddagger}||**

From the {ddagger}Laboratory of Medical Chemistry and Human Genetics and the §Laboratory of Virology and Immunology, Center for Cellular and Molecular Therapy, University of Liège, Sart-Tilman, 4000 Liège, Belgium, and the Laboratory of Molecular Virology, Department of Biological Chemistry, Institute of Biological and Molecular Medicine, Free University of Brussels, 6041 Gosselies, Belgium

I{kappa}B{alpha} is an inhibitory molecule that sequesters NF-{kappa}B dimers in the cytoplasm of unstimulated cells. Upon stimulation, NF-{kappa}B moves to the nucleus and induces the expression of a variety of genes including I{kappa}B{alpha}. This newly synthesized I{kappa}B{alpha} also translocates to the nucleus, removes activated NF-{kappa}B from its target genes, and brings it back to the cytoplasm to terminate the phase of NF-{kappa}B activation. We show here that I{kappa}B{alpha} enhances the transactivation potential of several homeodomain-containing proteins such as HOXB7 and Pit-1 through a NF-{kappa}B-independent association with histone deacetylase (HDAC) 1 and HDAC3 but not with HDAC2, -4, -5, and -6. I{kappa}B{alpha} bound both HDAC proteins through its ankyrin repeats, and this interaction was disrupted by p65. Immunofluorescence experiments demonstrated further that I{kappa}B{alpha} acts by partially redirecting HDAC3 to the cytoplasm. At the same time, an I{kappa}B{alpha} mutant, which lacked a functional nuclear localization sequence, interacted very efficiently with HDAC1 and -3 and intensively enhanced the transactivation potential of Pit-1. Our results support the hypothesis that the NF-{kappa}B inhibitor I{kappa}B{alpha} regulates the transcriptional activity of homeodomain-containing proteins positively through cytoplasmic sequestration of HDAC1 and HDAC3, a mechanism that would assign a new and unexpected role to I{kappa}B{alpha}.


Received for publication, June 17, 2003 , and in revised form, August 29, 2003.

* This work was supported by grants from the National Fund for Scientific Research, Belgium (F.N.R.S.) and TELEVIE and by the Belgian "Centre Anti-Cancéreux" (Ulg). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger}{ddagger} Part of a PAI (Pôle d'attraction inter-universitaire).

|| Research Associate at the F.N.R.S.

** To whom correspondence should be addressed: Laboratory of Medical Chemistry/CTCM, Pathology, +3 B23, C.H.U. Sart-Tilman, University of Liège, 4000 Liège, Belgium. Tel.: 32-4-366-24-86; Fax: 32-4-366-45-34; E-mail: Alain.chariot{at}ulg.ac.be.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
O. Kwon, K. A Kim, S. O. Kim, R. Ha, W. K. Oh, M. S. Kim, H. S. Kim, G. D. Kim, J. W. Kim, M. Jung, et al.
NF-{kappa}B inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells
Carcinogenesis, November 1, 2006; 27(11): 2258 - 2268.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
Y. Ma, J. Li, I. Chiu, Y. Wang, J. A. Sloane, J. Lu, B. Kosaras, R. L. Sidman, J. J. Volpe, and T. Vartanian
Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis
J. Cell Biol., October 23, 2006; 175(2): 209 - 215.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Gao, Q. He, B. Peng, P. J. Chiao, and J. Ye
Regulation of Nuclear Translocation of HDAC3 by I{kappa}B{alpha} Is Required for Tumor Necrosis Factor Inhibition of Peroxisome Proliferator-activated Receptor {gamma} Function
J. Biol. Chem., February 17, 2006; 281(7): 4540 - 4547.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Aguilera, R. Hoya-Arias, G. Haegeman, L. Espinosa, and A. Bigas
Recruitment of I{kappa}B{alpha} to the hes1 promoter is associated with transcriptional repression
PNAS, November 23, 2004; 101(47): 16537 - 16542.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. L. Hanson, N. A. Hawke, D. Kashatus, and A. S. Baldwin
The Nuclear Factor {kappa}B Subunits RelA/p65 and c-Rel Potentiate but Are Not Required for Ras-Induced Cellular Transformation
Cancer Res., October 15, 2004; 64(20): 7248 - 7255.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. V. Guseva, A. F. Taghiyev, M. T. Sturm, O. W. Rokhlin, and M. B. Cohen
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Activation of Mitochondria-Associated Nuclear Factor-{kappa}B in Prostatic Carcinoma Cell Lines
Mol. Cancer Res., October 1, 2004; 2(10): 574 - 584.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. G. Cosio, L. Tsaprouni, K. Ito, E. Jazrawi, I. M. Adcock, and P. J. Barnes
Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
J. Exp. Med., September 7, 2004; 200(5): 689 - 695.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ajenjo, E. Canon, I. Sanchez-Perez, D. Matallanas, J. Leon, R. Perona, and P. Crespo
Subcellular Localization Determines the Protective Effects of Activated ERK2 against Distinct Apoptogenic Stimuli in Myeloid Leukemia Cells
J. Biol. Chem., July 30, 2004; 279(31): 32813 - 32823.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.